当前位置：首页 > 文献互助 > 互助详情

期刊论文等离子表面改性实现原位生长高分辨率钙钛矿发光二极管复制

用户NNr4iMVW_-zw 1小时前 13 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-07-24 11:08:48 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.37188/CJL.20260028 复制

文献链接: https://cjl.lightpublishing.cn/zh/article/doi/10.37188/CJL.20260028/复制

其他信息:

上一篇：Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial

下一篇：Long-term safety and efficacy of intracortical microstimulation in humans

互助时间线

2026-07-17 11:18:58 [完结求助]

楼主确认了笑出声来应助的文件是正确的, 求助状态变成已完结

2026-07-17 11:08:48 [上传文件]

笑出声来上传了文件(pdf 2.28 MB), 求助状态变成待确认

2026-07-17 11:07:41 [发起求助]

最新发布的求助

Current Management of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Changing Landscape 13分钟前

Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study 21分钟前

Long-term safety and efficacy of intracortical microstimulation in humans 57分钟前

等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 1小时前

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 1小时前

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 1小时前

Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 1小时前

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 1小时前

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 1小时前

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 1小时前

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前